02:32 AM EDT, 07/29/2026 (MT Newswires) -- Nahdi Medical (SASE:4164) said Wednesday that its net profit for the first half decreased, while revenue rose year over year. Net profit attributable to shareholders of the issuer for the six months ended June 30 was 450.9 million Saudi riyals, compared with 493.6 million riyals a year ago. EPS moved to 3.47 riyals from 3.8 riyals. The Saudi Arabia-listed retail pharmacy and healthcare company's revenue was 5.47 billion riyals, compared with 5.16 billion riyals earlier. Meanwhile, the board resolved to distribute an unchanged cash dividend of 2.60 riyals per share for the first half, payable on Aug. 26 to shareholders on record as of Aug. 13.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.